Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
Yoshinari Shinsato(Kagoshima University), Kazunori Arita(Kagoshima University)
Cited by 78
Related Papers
Extracellular matrix dynamics in cell migration, invasion and tissue morphogenesis
|International Journal of Experimental Pathology|2019|120
Basement Membrane Regulates Fibronectin Organization Using Sliding Focal Adhesions Driven by a Contractile Winch
|Developmental Cell|2020|88
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme
|British Journal of Cancer|2019|46
Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
|Molecular and Clinical Oncology|2017|4